EXEL - EXELIXIS, INC.
IEX Last Trade
33.87
0.050 0.148%
Share volume: 9,179
Last Updated: Fri 27 Dec 2024 04:29:38 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.12%
PREVIOUS CLOSE
CHG
CHG%
$33.82
0.05
0.15%
View ratios
| Fiscal Date | 2022-07-01 | 2022-09-30 | 2022-12-30 | 2023-03-31 | 2023-06-30 | 2023-09-29 | 2023-12-29 | 2024-03-29 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-01 | 2023-02-07 | 2023-05-09 | 2023-08-01 | 2023-11-01 | 2024-02-06 | 2024-04-30 | |
| Total revenue | 419.427 M | 411.738 M | 423.917 M | 408.788 M | 469.848 M | 471.920 M | 479.652 M | 425.226 M | |
| Cost of revenue | 13.481 M | 15.305 M | 15.920 M | 14.315 M | 17.705 M | 18.774 M | 21.753 M | 21.256 M | |
| Gross profit | 405.946 M | 396.433 M | 407.997 M | 394.473 M | 452.143 M | 453.146 M | 457.899 M | 403.970 M | |
| -2.34% | 2.92% | -3.31% | 14.62% | 0.22% | 1.05% | -11.78% | |||
| Operating expenses | 322.240 M | 313.820 M | 456.075 M | 365.643 M | 374.293 M | 470.729 M | 376.111 M | 341.673 M | |
| Selling general and admin | 122.759 M | 114.983 M | 119.251 M | 131.397 M | 141.723 M | 138.144 M | 131.441 M | 113.984 M | |
| Research and development | 199.481 M | 198.837 M | 336.824 M | 234.246 M | 232.570 M | 332.585 M | 244.670 M | 227.689 M | |
| Total expenses | 335.721 M | 329.125 M | 471.995 M | 379.958 M | 391.998 M | 489.503 M | 397.864 M | 362.929 M | |
| -1.96% | 43.41% | -19.50% | 3.17% | 24.87% | -18.72% | -8.78% | |||
| Operating income | 83.706 M | 82.613 M | -48.078 M | 28.830 M | 77.850 M | -17.583 M | 81.788 M | 62.297 M | |
| Ebit | 83.706 M | 82.613 M | -48.078 M | 28.830 M | 77.850 M | -17.583 M | 81.788 M | 62.297 M | |
| Pretax income | 88.508 M | 92.042 M | -31.427 M | 48.278 M | 100.386 M | 5.818 M | 103.039 M | 49.267 M | |
| 3.99% | -134.14% | -253.62% | 107.93% | -94.20% | 1,671.04% | -52.19% | |||
| Income tax | 17.836 M | 18.832 M | -1.254 M | 8.250 M | 19.208 M | 4.777 M | 17.521 M | 11.950 M | |
| Net income basic | 70.672 M | 73.210 M | -30.173 M | 40.028 M | 81.178 M | 1.041 M | 85.518 M | 37.317 M | |
| 3.59% | -141.21% | 232.66% | 102.80% | -98.72% | 8,114.99% | -56.36% | |||
| Net income | 70.672 M | 73.210 M | -30.173 M | 40.028 M | 81.178 M | 1.041 M | 85.518 M | 37.317 M | |
| 3.59% | -141.21% | 232.66% | 102.80% | -98.72% | 8,114.99% | -56.36% |